N Terminal–Pro Brain Natriuretic Peptide (Nt-ProBNP) in Patients Hypertension Stage 1 And Stage 2
Downloads
The level of N Terminal – Pro Brain Natriuretic Peptide was independently associated with an increased risk of hypertension. This study aimed to determine the difference of NT-proBNP serum levels and the correlation between the levels of NT-proBNP in patients with hypertension stage 1 and stage 2. This research was conducted at RSUP dr. Wahidin Sudirohusodo in August -September 2018. The research was conducted at Dr. Wahidin Sudirohusodo RSUP from August through September 2018. The study used a cross-sectional design with a total of 72 hypertensive patients, who had met the inclusive criteria. NT-proBNP levels were measured using the ELISA (Enzyme-Linked Immunosorbent Assay) method. The collected data is processed using Mann Whitney Different Test and Spearman's rho Correlation Test. The study results indicated that the level of NT-proBNP in the hypertensive patients with stage 2 (172.85 + 316.26) was higher and significantly different (p = <0.001) compared to hypertensive patients stage 1 (34.98 + 28.99). NT-proBNP levels were higher in the hypertensive group of >6 years (247.83+361.01) than in the hypertensive group <6 years (62.79+164.66), statistically there were significant differences between the two groups (p=0.010). There was in a significant correlation between the levels of NT-proBNP in hypertensive patients, stage 1 and stage 2 (p = 0.862) even though it showed significantly different results.
Azhar, I. (2017). Gambaran Karakteristik Pasien Hipertensi di Puskesmas Gamping Sleman Yogyakarta.Yogyakarta: Sekolah Tinggi Ilmu Kesehatan Universitas Jenderal Achmad Yani Yogyakarta.
Bower et al., (2015). N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) and Risk of Hypertension in the Atherosclerosis Risk in Communities (ARIC) Study.American Journal of Hypertension. 28(10): 1262 - 1266.
Joint National Committee (JNC) VII. (2003). The Sevent Report of The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. U.S: Department of Health And Human Services.
Karmelia T., Waspadji S., Makmun L. H., Effendi S., Ramli M. & Timan I.S. (2017). Perubahan Konsentrasi Amino Terminal Pro B-Type Natriuretic Peptide (NT-proBNP) dan Fraksi Ejeksi Ventrikel Kiri pada Pasien Kemoterapi Doksorubisin.Jurnal Penyakit Dalam Indonesia. 4(2): 78 - 82.
Khairunnisa. (2017). Korelasi Kadar NT – proBNP dengan Fungsi Fraksi Ejeksi Ventrikel Kiri pada Gagal Jantung Anak. Padang: Program Pasca Sarjana Ilmu Biomedik – Program Pendidikan Dokter Spesialis FK UNAND – RS.M. DJAMIL.
Muhadi. (2016). JNC 8: Evidence-based Guideline. Penanganan Pasien Hipertensi Dewasa, (Online), Vol. 43, No.1, (www.cdkjournal.com/index.php/CDK/article/, diakses 14 Januari 2018).
Munir, A. & Sargowo, N. (2010).N Terminal-Pro Brain Natriuretic Peptide as Indicator of Left Ventricle Hypertropy In Hypertensive Patients Compared with Left Ventricle Mass Index in Echocardiography. Jurnal Kardiologi Indonesia.Vol 31 No 2: 87 – 98.
Perhimpunan Dokter Spesialis Kardiovaskular Indonesia (Perki).(2015). Pedoman Tatalaksana Hipertensi pada Penyakit Kardiovaskular. Edisi I. Jakarta: Perhimpunan Dokter Spesialis Kardiovaskular Indonesia.
Renardi, T. R. (2009). Hubungan Nilai N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) dengan Keparahan Penderita Gagal Jantung. Medan: Departemen Ilmu Penyakit Dalam Fakultas Kedokteran Universitas Sumatera Utara.
Rilantono, L.I. (2016). Penyakit Kardiovaskular. Jakarta: Fakultas Kedokteran Universitas Indonesia.
Riset Kesehatan Dasar (RISKESDAS). (2013). Badan Penelitian dan Pengembangan Kesehatan. Jakarta: Kementerian Kesehatan RI.
Rosello et al., (2012). Variability of NT-proBNP and Its Relationship with Inflammatory Status in Patients with Stable Essential Hypertension.PLOS Journals.Vol 7 No 1.
Sarzani, R. et al (2016). NT-proBNP and Its Correlation Hospital Mortality in the Very Elderly without and Admission Diagnosis of Heart Failue.PLOS Journals.Vol 10 No 1371.
Stefannus, M. (2015). Hubungan Positif Antara Derajat Penyakit Sirosis Hati dengan N Terminal – pro Brain Natriuretic Peptide (NT-proBNP) pada Sirosis Hati. Denpasar: Program Magister Ilmu Biomedik Universitas UDAYANA.
World Health Organization (WHO).(2013). Calls for Intensiified Efforts to Prevent and Control Hypertension, (Online), (http://www.who.int/ workforcealiance/media/news/, diakses 16 Februari 2018).
Copyright (c) 2019 JURNAL INFO KESEHATAN
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright notice
Ownership of copyright
The copyright in this website and the material on this website (including without limitation the text, computer code, artwork, photographs, images, music, audio material, video material and audio-visual material on this website) is owned by JURNAL INFO KESEHATAN and its licensors.
Copyright license
JURNAL INFO KESEHATAN grants to you a worldwide non-exclusive royalty-free revocable license to:
- view this website and the material on this website on a computer or mobile device via a web browser;
- copy and store this website and the material on this website in your web browser cache memory; and
- print pages from this website for your use.
- All articles published by JURNAL INFO KESEHATAN are licensed under the Creative Commons Attribution 4.0 International License. This permits anyone to copy, redistribute, remix, transmit and adapt the work provided the original work and source is appropriately cited.
JURNAL INFO KESEHATAN does not grant you any other rights in relation to this website or the material on this website. In other words, all other rights are reserved.
For the avoidance of doubt, you must not adapt, edit, change, transform, publish, republish, distribute, redistribute, broadcast, rebroadcast or show or play in public this website or the material on this website (in any form or media) without appropriately and conspicuously citing the original work and source or JURNAL INFO KESEHATAN prior written permission.
Permissions
You may request permission to use the copyright materials on this website by writing to jurnalinfokesehatan@gmail.com.
Enforcement of copyright
JURNAL INFO KESEHATAN takes the protection of its copyright very seriously.
If JURNAL INFO KESEHATAN discovers that you have used its copyright materials in contravention of the license above, JURNAL INFO KESEHATAN may bring legal proceedings against you seeking monetary damages and an injunction to stop you using those materials. You could also be ordered to pay legal costs.
If you become aware of any use of JURNAL INFO KESEHATAN copyright materials that contravenes or may contravene the license above, please report this by email to jurnalinfokesehatan@gmail.com
Infringing material
If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to jurnalinfokesehatan@gmail.com.
